Q4 2024 Earnings Call Transcript March 5, 2025 EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.64 EPS, expectations were $-0.54. Tessa Romero – JPMorgan: Yigal ...

That, in all statistical likelihood, will probably be our Finals matchup. But doubt the reigning NBA champion Boston Celtics at your own risk. And even if they have some drawbacks that should give ...

Mounting competition in the sector and rising obesity have led the pharmaceutical company to start selling the drug directly ...

In a strategic partnership with Raydium Solutions, Apollo Group TV is making premium streaming more accessible by introducing ...

The trading has begun in the NHL, and you should expect more moves before the flurry of action is unleashed on Friday, which ...

VOQUEZNA® (vonoprazan) generated $55.3 million in 2024 net revenues in its first full year of launch, driven by strong demand, including $29.7 million in Q4, an 81% increase from Q3Over 300,000 filled ...

Bayer Aktiengesellschaft ( OTCPK:BAYZF) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ET Jost Reinhard - IR Bill Anderson - Chairman & CEO Wolfgang Nickl - CFO Rodrigo Santos - President, ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...